HIV-1 Tat protein (Trans-Activator of Transcription) (Tat)
Target
Tat
Molecular classification
Viral regulatory protein, Transcription factor, RNA-binding protein
01
Overview
HIV-1 Tat (Trans-Activator of Transcription) is a small, essential regulatory viral protein of 84–104 amino acids that functions as the master switch controlling HIV-1 gene expression. The protein's primary role is to activate viral transcription by binding to a stem-loop RNA structure called the transactivating response element (TAR) located at the 5' end of all viral transcripts. Tat accomplishes this by recruiting the host cell super elongation complex (SEC), particularly the P-TEFb component, which phosphorylates and activates RNA polymerase II, enabling it to transcribe the complete viral genome. Beyond its direct role in viral replication, Tat modulates the expression of hundreds of cellular genes, effectively remodeling the host cell environment to support HIV production and persistence. The protein also interacts with chromatin-modifying enzymes and structural proteins, which can lead to chromosomal aberrations associated with HIV-induced oncogenesis. As a therapeutic target, Tat represents an important avenue for HIV cure strategies, as disrupting Tat function or its interactions with cellular transcriptional machinery could reverse HIV latency and eliminate persistent infections.
Other names
Trans-activator of transcriptionTransactivator proteinHIV-1 TatTat protein
02
Mechanism of action
Mechanism of action for targeting Tat involves disruption of Tat:TAR:P-TEFb complex formation, inhibition of Tat-mediated recruitment of transcriptional elongation factors, blocking Tat interactions with chromatin-modifying enzymes, and prevention of Tat-dependent viral transcription activation.
03
Biological functions
HIV-1 gene expression activation: The major function of Tat is activation of HIV-1 viral transcription by binding to the transactivating response element (TAR) RNATranscriptional elongation regulation: Tat recruits the positive transcription elongation factor b (P-TEFb) complex to release paused RNA polymerase II, converting it into a highly processive enzyme capable of transcribing the entire viral genomeChromatin remodeling: Tat recruits histone acetyltransferases (HATs) and chromatin-modifying complexes to the HIV-1 promoter, relieving nucleosome-mediated repressionCellular gene expression modulation: Tat interacts with approximately 568 cellular genes to modulate host cell gene expression and create an environment favorable for viral productionNuclear and nucleolar localization: Tat localizes to both the nucleoplasm and nucleolus depending on its concentration, with distinct functional roles in each compartment
04
Disease associations
HIV-1 infection: Essential for productive HIV-1 replicationHIV-induced oncogenesis: Tat can interact with chromatin proteins and potentially lead to chromosomal aberrations and oncogenesis in HIV-infected patientsAIDS-dementia complex: Tat has been detected in the central nervous system of HIV-infected patients with AIDS-dementia symptoms
05
Safety considerations
Off-target effects on host transcription: Tat modulates expression of numerous cellular genes, and therapeutic targeting could disrupt critical host cell functionsPotential for chromosomal instability: Tat interactions with chromatin proteins and chromosome condensation machinery could theoretically increase oncogenic risk if dysregulatedCentral nervous system penetration: Tat presence in the CNS complicates therapeutic design for neurological manifestations of HIV infection
06
Biomarkers
Tat protein localization patterns (nucleoplasmic vs. nucleolar distribution) correlate with viral infection state and Tat concentrationProteomic signatures of Tat expression, including enrichment of ribosomal biogenesis and metabolic pathway proteins
Beyond the preview
Go deeper on HIV-1 Tat protein (Trans-Activator of Transcription) (Tat).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on HIV-1 Tat protein (Trans-Activator of Transcription) (Tat).